G Protein-coupled receptors
|
|
Ion channels
|
|
Nuclear receptors
|
|
Protein kinases
|
|
Cytokines and receptors
|
|
Cell surface molecules and ligands
|
|
Transporters
|
|
Enzymes
|
Oxidoreductases (EC1)
|
Dehydrogenases [EC:1.1.1.-]
|
Oxidases [EC:1.1.3.-]
|
Dehydrogenases [EC:1.2.1.-]
|
Dehydrogenases [EC:1.3.-.-]
|
Amine oxidases [EC:1.4.3.-]
|
Dihydrofolate reductase [EC:1.5.1.3]
|
NAD(P)H dehydrogenase [EC:1.6.5.2]
|
Peroxidase [EC:1.11.1.-]
|
Peroxygenase [EC:1.11.2.-]
|
Dioxygenases [EC:1.13.11.-]
|
Prolyl 4-hydroxylase [EC:1.14.11.2]
|
HIF hydroxylase [EC:1.14.11.29]
|
Nitic oxide synthase [EC:1.14.13.39]
|
Cytochrome P450 [EC:1.14.14.-]
|
CYP3A [HSA:1551 1576 1577 64816] [KO:K17691 K17689 K17690 K17692]
|
CYP19A1 (ARO) [HSA:1588] [KO:K07434]
|
D00574 Aminoglutethimide (USP/INN)
D07260 Formestane (INN)
D00960 Anastrozole (JP18/USP/INN) <JP/US>
D00964 Letrozole (JAN/USP/INN) <JP/US>
D03786 Vorozole (USAN/INN)
D00963 Exemestane (JAN/USP/INN) <JP/US>
D00153 Testolactone (USP/INN)
D02451 Fadrozole hydrochloride (USAN)
D03749 Plomestane (USAN/INN)
D03778 Fadrozole hydrochloride hydrate (JAN)
D03781 Liarozole fumarate (USAN)
D03784 Liarozole hydrochloride (USAN)
D05746 Rogletimide (USAN/INN)
D07940 Fadrozole (INN)
|
CYP17A1 [HSA:1586] [KO:K00512]
|
CYP46A1 [HSA:10858] [KO:K07440]
|
CYP51A1 [HSA:1595] [KO:K05917]
|
CYP11B1 [HSA:1584] [KO:K00497]
|
CYP11B2 [HSA:1585] [KO:K07433]
|
CYP11A1 [HSA:1583] [KO:K00498]
|
CYP26 [HSA:1592 56603 340665] [KO:K07437 K12664 K12665]
|
Other monooxygenases [EC:1.14.16.- 1.14.17.- 1.14.18.-]
|
Prostaglandin synthase [EC:1.14.99.1]
|
Histone demethylase [EC:1.14.99.66]
|
Superoxide dismutase [EC:1.15.1.1]
|
Xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
|
Ribonucleoside-diphosphate reductase [EC:1.17.4.1]
|
Vitamin-K-epoxide reductase [EC:1.17.4.4]
|
Thyroxine 5'-deiodinase [EC:1.21.99.4]
|
Transferases (EC2)
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
|
Nucleic acids
|
|
Not elsewhere classified
|